Pra Health Sciences Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2021 to a ratio of 4.35, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the first quarter 2021. Average receivable collection period, for the Pra Health Sciences Inc in Mar 31 2021 quarter, has decreased to 84 days, compared to 85 days, in the Dec 31 2020 quarter.

If we take a look into Healthcare sector 88 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 1122.

What is Receivable Turnover Ratio?
What is Pra Health Sciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PRAH Receivables Turnover Ratio	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter
Y / Y Receivable Change	12.58 %	28.15 %	0.88 %	14.9 %	15.91 %
Y / Y Revenue Change	19.15 %	9.15 %	2 %	-4.38 %	8.54 %
Receivable Turnover Ratio (TTM)	4.35	4.28	4.46	4.44	4.65
PRAH's Total Ranking	# 1122	# 1122	# 2981	# 1122	# 2984
Accounts Receivable average collection period days	84	85	82	82	79
Seq. Receivable Change	-7.65 %	19.06 %	-3.24 %	5.82 %	5.12 %
Seq. Revenue Change	6.91 %	9.69 %	9.1 %	-6.87 %	-2.07 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 6
Healthcare Sector	# 89
Overall Market	# 1122

Receivable Turnover Ratio Statistics
High	Average	Low
0.89	0.84	0.74
(Dec 31 2018)		(Mar 31 2016)

PRAH Company Profile • Back to PRAH Efficiency Comparisons • Compare PRAH Receivables Turnover Ratio to its Competitors

Financial Statements
Pra Health Sciences Inc 's Accounts Receivable	$ 779 Millions	Visit PRAH's Balance sheet
Pra Health Sciences Inc 's Sales TTM	$ 3,333 Millions	Visit PRAH's Income Statement
Sources of PRAH's Revenues		Visit PRAH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PRAH's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PRAH's Growth Rates	PRAH's Roa	PRAH's Inventory Turnover Ratio	PRAH's Dividend Comparisons
PRAH's Profitability Ratios	PRAH's Roi	PRAH's Asset Turnover Ratio	PRAH's Dividend Growth
PRAH's Valuation Ratios	PRAH's Roe	PRAH's Financial Strength Ratios	PRAH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2021	Receivable at quarter ending Mar 31 2021
Fulcrum Therapeutics Inc	11.67	$ 12.862 Millions	$ 1.103 Millions
Chembio Diagnostics Inc	11.52	$ 34.335 Millions	$ 2.981 Millions
Xencor Inc	11.50	$ 124.274 Millions	$ 10.808 Millions
Allied Healthcare Products inc	11.36	$ 37.771 Millions	$ 3.325 Millions
Strongbridge Biopharma plc	11.36	$ 32.439 Millions	$ 2.857 Millions
Teladoc Health Inc	11.31	$ 1,164.316 Millions	$ 102.942 Millions
Viemed Healthcare Inc	11.29	$ 135.919 Millions	$ 12.043 Millions
Integrated Biopharma Inc	11.25	$ 60.036 Millions	$ 5.339 Millions
Morphic Holding inc	11.19	$ 42.616 Millions	$ 3.810 Millions
National Healthcare Corp	11.16	$ 1,023.066 Millions	$ 91.698 Millions
Insulet Corporation	11.11	$ 958.700 Millions	$ 86.275 Millions
Novavax inc	11.10	$ 919.450 Millions	$ 82.816 Millions
Vaso Corporation	10.95	$ 69.086 Millions	$ 6.309 Millions
American Bio Medica Corporation	10.93	$ 3.984 Millions	$ 0.365 Millions
Scienture Holdings Inc	10.65	$ 17.972 Millions	$ 1.687 Millions
Puma Biotechnology Inc	10.58	$ 272.062 Millions	$ 25.706 Millions
Ontrak Inc	10.41	$ 99.221 Millions	$ 9.533 Millions
Musclepharm Corporation	10.40	$ 61.330 Millions	$ 5.898 Millions
Insmed Inc	10.39	$ 167.767 Millions	$ 16.140 Millions
Utah Medical Products Inc	10.35	$ 42.240 Millions	$ 4.083 Millions
Procyon Corporation	10.24	$ 4.338 Millions	$ 0.423 Millions
Kushco Holdings Inc	10.10	$ 108.585 Millions	$ 10.749 Millions
Avita Medical Inc	10.09	$ 22.805 Millions	$ 2.259 Millions
Crispr Therapeutics Ag	10.08	$ 1.101 Millions	$ 0.109 Millions
Enzo Biochem Inc	10.05	$ 112.445 Millions	$ 11.191 Millions
Dicerna Pharmaceuticals Inc	10.02	$ 177.882 Millions	$ 17.755 Millions
Capricor Therapeutics inc	9.91	$ 0.165 Millions	$ 0.017 Millions
Capforce Inc	9.87	$ 4.427 Millions	$ 0.448 Millions
United Therapeutics Corporation	9.67	$ 1,506.100 Millions	$ 155.700 Millions
The Pennant Group Inc	9.65	$ 404.767 Millions	$ 41.925 Millions

Date modified: 2026-06-22T16:30:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.